Advanced Health Intelligence (NASDAQ:AHI, ASX:AHI) is committed to becoming a global leader in digital health. We harness proprietary technology and innovative processes to redefine health screening. Leveraging the ubiquity and convenience of smartphones, AHI aims to deliver a comprehensive suite of assessment tools globally to healthcare providers, caregivers, insurers, and governments. Our mission is to enhance healthcare delivery and support the early detection and prevention of chronic diseases. Our patented technology has evolved into a robust suite of solutions that symbolize the future of digitized healthcare. These include: • Body dimension and composition assessments, enabling the identification of obesity-related comorbidities such as diabetes. • Blood biomarker prediction, inclusive of HbA1C, HDL, LDL, and 10-year mortality risk. • Transdermal Optical Imaging, providing vital signs and cardiovascular disease risk estimates. • On-device dermatological skin identification, capable of recognizing 588 skin conditions across 133 categories, including melanoma. • Assisting partners in delivering personalized therapeutic and non-therapeutic health coaching to improve daily habits and build health literacy. Our world-class team—comprising machine learning and AI experts, computer vision specialists, and medically trained data scientists—ensures that AHI remains at the cutting edge of health-tech innovation. We aspire to create a transformative impact at scale, driving forward a new era in digital healthcare. Our biometrically derived triage solution, accessible via smartphone, enables our partners to identify and manage health risks at a population scale. Through technology, AHI contributes to a more efficient, effective, and inclusive global healthcare system. We stand ready to guide healthcare providers, caregivers, insurers, and governments in triaging individuals into the most suitable care pathways.